Fast-Track the Discovery & Development of Next Generation Degraders to Tackle Challenging & Diverse Targets, Nourish Pre-Clinical Pipelines by Overcoming Selectivity Challenges, & Accelerate Clinical Degraders Towards the First Approval

The 5th Annual Targeted Protein Degradation Summit returns to Boston this October with the most comprehensive agenda to date. Branded the ‘most important event for the TPD community’ by many key opinion leaders, this is your premium opportunity to catch up on the most pertinent translational, clinical, and discovery progress from the key labs globally.

Our 2022 event will welcome first disclosures of exciting data with important learnings being communicated so the field can advance towards the first approval.

Covering the very latest from PROTACs and molecular glues in the clinic, to unveiling next generation strategies including AbTACs, DUBTACs, bioPROTACs, ATACs, RESTORACs and more, this conference gives you a prime opportunity to troubleshoot challenging problems and inspire new ideas in one another.